Minor
CALMA · Agitation in Alzheimer's Dementia
Enrollment closed, study ongoing
Also in this update: Primary and study completion pushed from Aug 2026 to Nov 2026; Trial sites reduced: 31 → 28 locations
IGC Pharma, LLCPhase 2 NCT05543681 Registry history of NCT05543681 on ClinicalTrials.gov (opens the registry)